Microtiter plate assays to assess antibiofilm activity against bacteria

被引:111
作者
Haney, Evan F. [1 ]
Trimble, Michael J. [1 ]
Hancock, Robert E. W. [1 ]
机构
[1] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada
基金
加拿大健康研究院;
关键词
CALGARY BIOFILM DEVICE; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; IN-VITRO; SUSCEPTIBILITY; QUANTIFICATION; PEPTIDES; EVALUATE; GROWTH; MODEL;
D O I
10.1038/s41596-021-00515-3
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Bacterial biofilms demonstrate high broad-spectrum adaptive antibiotic resistance and cause two thirds of all infections, but there is a lack of approved antibiofilm agents. Unlike the standard minimal inhibitory concentration assay to assess antibacterial activity against planktonic cells, there is no standardized method to evaluate biofilm inhibition and/or eradication capacity of novel antibiofilm compounds. The protocol described here outlines simple and reproducible methods for assessing the biofilm inhibition and eradication capacities of novel antibiofilm agents against adherent bacterial biofilms grown in 96-well microtiter plates. It employs two inexpensive dyes: crystal violet to stain adhered biofilm biomass and 2,3,5-triphenyl tetrazolium chloride to quantify metabolism of the biofilm cells. The procedure is accessible to any laboratory with a plate reader, requires minimal technical expertise or training and takes 4 or 5 d to complete. Recommendations for how biofilm inhibition and eradication results should be interpreted and presented are also described. This protocol outlines simple and reproducible methods for assessing the biofilm inhibition and eradication capacities of novel antibiofilm agents against adherent bacterial biofilms grown in 96-well microtiter plates.
引用
收藏
页码:2615 / 2632
页数:20
相关论文
共 51 条
  • [1] Investigating the suitability of the Calgary Biofilm Device for assessing the antimicrobial efficacy of new agents
    Ali, Laila
    Khambaty, Farukh
    Diachenko, Gregory
    [J]. BIORESOURCE TECHNOLOGY, 2006, 97 (15) : 1887 - 1893
  • [2] [Anonymous], 2017, CRIT REV MICROBIOL, DOI DOI 10.1080/1040841X.2016.1208146
  • [3] Effect of growth media on the MTT colorimetric assay in bacteria
    Benov, Ludmil
    [J]. PLOS ONE, 2019, 14 (08):
  • [4] High-Throughput Screening of Metal-N-Heterocyclic Carbene Complexes against Biofilm Formation by Pathogenic Bacteria
    Bernardi, Thierry
    Badel, Stephanie
    Mayer, Pascal
    Groelly, Jerome
    de Fremont, Pierre
    Jacques, Beatrice
    Braunstein, Pierre
    Teyssot, Marie-Laure
    Gaulier, Christelle
    Cisnetti, Federico
    Gautier, Arnaud
    Roland, Sylvain
    [J]. CHEMMEDCHEM, 2014, 9 (06) : 1140 - 1144
  • [5] Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7
  • [6] Use of the Gram stain in microbiology
    Beveridge, TJ
    [J]. BIOTECHNIC & HISTOCHEMISTRY, 2001, 76 (03) : 111 - 118
  • [7] The role of bacterial biofilms in chronic infections
    Bjarnsholt, Thomas
    [J]. APMIS, 2013, 121 : 1 - 58
  • [8] The biofilm architecture of sixty opportunistic pathogens deciphered using a high throughput CLSM method
    Bridier, A.
    Dubois-Brissonnet, F.
    Boubetra, A.
    Thomas, V.
    Briandet, R.
    [J]. JOURNAL OF MICROBIOLOGICAL METHODS, 2010, 82 (01) : 64 - 70
  • [9] Medical Biofilms
    Bryers, James D.
    [J]. BIOTECHNOLOGY AND BIOENGINEERING, 2008, 100 (01) : 1 - 18
  • [10] The Calgary Biofilm Device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms
    Ceri, H
    Olson, ME
    Stremick, C
    Read, RR
    Morck, D
    Buret, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (06) : 1771 - 1776